Lvmh Recherche

Parfums Christian Dior

Institut National De La Sante Et De La Recherche Medicale

Centre National De La Recherche Scientifique

Universite Claude Bernard – Lyon1

Other

Biomerieux, Inc.

Université De Picardie Jules Verne

Poxel

Ens-Ecole Normale Superieure De Lyon

Edelris

Universitéde Strasbourg

Guerlain

Patrice Andre

Isabelle Renimel

Vincent Lotteau

Jean-Christophe Archambault

Michel Hocquaux

Florence Pilard

Céline Godenir

Nicolas Thiebault

Vincent Moreau

Daniel Cravo

Didier Roche

Sophie Hallakou-Bozec

Gerard Redziniak

Virginie Pecher

Virginie Leplanquais

Amaury Patin

Pierre Perrier

Sylvie Darnault

Nancy Sauvan

Marine Gilardone

Michel Garcia

Marc Olivier

Pauline Radreau

Gerald Guillaumet

Benoît De Chassey

Rolf Zinkernagel

Marielle Moreau

Paul Klenerman

Valerie Thiery

Cécile Lamy

Francine Joly

Emmanuelle Noblesse

Laurene Meyniel-Schicklin

Anne Aublin-Gex

Fran&ccedil;oise Pellicier

St&eacute;phane Lhermite

Marcus Groettrup

Val&eacute;rie Krzych

C&eacute;cile Viron

Charlotte Simmler

Pierre Cabalion

Jocelyne Dominice

Annelise Lobstein

Claude Andary

Francedillaoise Pellicier

Stephane Lhermite

Elodie Verdier

Clarisse Marteau

Hanitriniaina Razafimambimby

The invention relates to a cosmetic composition comprising at least one extract from the orchidas an active agent and at least one cosmetically acceptable excipient. The invention relates to the use in a cosmetic composition of an extract from the orchidas an active agent for preventing or delaying the appearance of the signs of skin ageing or for slowing or attenuating the effects thereof, or else also for promoting cell or tissue longevity. The invention in particular relates to an orchid extract inhibiting the expression and/or the activity of the mitochondrial protein Smac/DIABLO.

[object Object]

The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to farnesoid X receptor (FXR) agonists for use in a method for the treatment of hepatitis B virus infection in a subject in need thereof.

Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection

Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection

The invention relates to a dyestuff of plant origin, obtained from a colored part of a plant species, the cell tissues of which contain iridisomes responsible for the coloration of said part. It relates most particularly to a blue dyestuff obtained from the arils of the seeds of the plant species. It also relates to compositions, in particular cosmetic compositions, especially intended for making up the skin or superficial body growths, containing said dyestuff.

Dyestuffs of plant origin and use thereof for colouring compositions, in particular cosmetic compositions

The present invention relates to the use of an alkyl glycoside or of a mixture of at least two alkyl glycosides as agent intended for inhibiting microbial growth, in particular in a cosmetic, pharmaceutical or food composition.

Methods of inhibiting microbial growth using deoxyaldohexoses

The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3'-monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.

Methods and pharmaceutical compositions for inhibiting influenza viruses replication

The present invention relates to cosmetic or dermatological compositions comprising a combination of a cannabis essential oil substantially free of cannabinoids and a helichrysum essential oil, and to their uses thereof, particularly for the care of sensitive or sensitized skin.

Cosmetic or dermatological compositions comprising a mixture of essential oils, and its uses thereof, particularly for the care of sensitive or sensitized skin

The invention relates to novel eucomic acid (2-(4-hydroxybenzyl)malic acid) derivatives or plant extracts comprising such derivatives, and also to cosmetic or dermatological compositions containing these compounds or these extracts, and to cosmetic care methods using said compositions. Exemplary compounds are represented by formula (I) below: 

Cosmetic composition

The present invention relates to a method for preparing a lipophilic extract from lignified portions of vine, such as shoots, stock and roots, characterized in that said method comprises a step for extraction from said lignified portions with an apolar solvent; to an extract obtained by such a method; to the use of such an extract as an excipient in a cosmetic composition; and to a cosmetic composition comprising such an extract.

Method for preparing a lipophilic vine extract

An extract is from the plant. The sap from the plantor of an extract of that plant is used as a hydrating active agent in a cosmetic composition, to restore, maintain or reinforce the hydration state of the skin.

The present invention relates to a novel use of alkyl glycosides and of mixtures of alkyl glycosides having anti-ageing and/or calming properties as active agents in cosmetic compositions, and to methods of cosmetic care using the said compositions.

Use of an alkyl glycoside or of a mixture of alkyl glycosides having anti-ageing and/or calming properties as active agents in cosmetic compositions, and methods of cosmetic care using said compositions

Use of alkyl glycosides as agents for inhibiting microbial growth and compositions containing them

Cosmetic compositions with anti-free radical activity have been developed. Such compositions preferably contain an association of at least the following three substances with anti-free radical activity: an extract of emblica, idebenone and N-acetylcysteine.

Cosmetic composition with anti-free radical activity

Cosmetic compositions with anti-free radical activity have been developed. Such compositions preferably contain an association of at least the following three substances with anti-free radical activity: idebenone; N-acetylcysteine, and alpha-tocotrienol or an ester thereof with a C-Corganic acid.

The invention relates to a solid coloring material obtained by precipitation, in an aqueous medium, of the reaction product of an alkali metal silicate with a colored complex obtained by reaction, in aqueous solution, of a hydrolysable tannin or of a plant extract comprising it with a salt of a metal cation. The invention also relates to a cosmetic composition intended for making up the skin or superficial body growths comprising this coloring material. It also relates to a method for making up the skin or superficial body growths comprising the topical application of this cosmetic composition.

Coloring material and its uses, in particular in the field of cosmetics, especially for making up the skin and superficial body growths

Growing community of inventors

Neuville aux Bois, France

Patrice Andre